Surrey Heartlands

Joint Formulary & PAD

Olanzapine - Schizophrenia and other psychoses

You are here : Home > Formulary Search > Olanzapine - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

 

Status 2

Blue
Formulations :
  • Oro-dispersible tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Reserve orodispersible tablets for patients with swallowing difficulties or administration via a PEG tube. 

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

 

Status 3

Red
Formulations :
  • Depot injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Olanzapine embonate - maintenance in schizophrenia.
Not suitable for  administration under the locally commissioned service (LCS).
Note 3 hour monitoring after dose .

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
Brand Names Include :
Zypadhera, Zyprexa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Olanzapine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia and other psychoses.

Committee Recommendations (0)

  • No records returned.